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O B J E C T I V E S We investigated whether cardiac sympathetic nervous system (SNS) activity mea-
sured by iodine-123 meta-iodobenzylguanidine (123I-mIBG) imaging would be associated with both the
occurrence of heart failure (HF) and the transit to permanent atrial ﬁbrillation (AF) in patients with
paroxysmal AF.
B A C KG ROUND Atrial ﬁbrillation occurs suddenly and transiently and can persist, and results in the
occurrence of HF. An important feature of AF and HF is their propensity to coexist not only because they
share antecedent risk factors, but also because the one may directly predispose the heart to the other.
However, a useful modality for predicting the occurrences of both those has not been established in
patients with paroxysmal AF.
METHOD S The 123I-mIBG scintigraphy was performed to evaluate cardiac SNS activity presented as
the heart/mediastinum ratio in 98 consecutive patients (age 66  13 years, 63.3% male) with idiopathic
paroxysmal AF and preserved left ventricular ejection fraction (50%).
R E S U L T S During 4  3.6 years of follow-up, the transit to permanent AF was associated with the
occurrence of HF (34.3% in 12 of 35 patients with permanent AF vs. 6.3% in 4 of 63 patients without, p
0.0001). Lower heart/mediastinum ratio and lower left ventricular ejection fraction were the indepen-
dent predictors of the transit to permanent AF with adjusted hazard ratios of 3.44 (95% conﬁdence
interval [CI]: 1.9 to 6.2, p  0.0001) and 1.04 (95% CI: 1.01 to 1.08, p  0.014). Further, these factors and
higher plasma brain natriuretic peptide concentration were the independent predictors of the
occurrence of HF with permanent AF, with adjusted hazard ratios of 5.08 (95% CI: 1.5 to 17.5, p 0.011),
1.11 (95% CI: 1.03 to 1.19, p  0.004), and 1.004 (95% CI: 1.001 to 1.008, p  0.014).
CONC L U S I O N S Cardiac SNS abnormality was associated with the occurrence of both HF and
permanent AF in paroxysmal AF patients, and 123I-mIBG imaging may be a useful modality for predicting
the development of AF. (J Am Coll Cardiol Img 2011;4:78–86) © 2011 by the American College of
Cardiology Foundation
From the *Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan, and the
†Department of Radiology, Showa University School of Medicine, Tokyo, Japan. All authors have reported that they have no
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79trial fibrillation (AF) occurs suddenly and
transiently, and can be perpetuated, and
results in the occurrence of heart failure
(HF). AF and HF have emerged as new
ardiovascular epidemics over the last decade (1).
F facilitates the development or progression of
F by reduction of cardiac output, which results
rom enlargement of left atrial size, rapid ventricular
ate, irregular rate, valvular inefficiency, and left
entricular dysfunction with tachycardia-induced
ardiomyopathy (2). However, the majority of AF
See page 87
atients with HF do not have a reduced left
entricular ejection fraction (LVEF) (3,4). An im-
ortant feature of permanent AF and occurrence of
F is their propensity to coexist, not only because
hey share antecedent risk factors, but also because
he one may directly predispose the heart to the
ther. More important, it is widely perceived that
he combination of these conditions carries a worse
rognosis than does either alone. However, the
aroxysmal occurrence of AF does not always result
n the development of permanent AF and HF.
herefore, a recent report from a National Heart,
ung and Blood Institute workshop has recom-
ended researching noninvasive modalities for
dentifying key components of cardiovascular re-
odeling factors that promote AF (5). As pointed
ut in that workshop, the autonomic nervous sys-
em plays an important role for both the develop-
ent of permanent AF from paroxysmal AF (6,7)
nd the occurrence of HF (8). Iodine-123 meta-
odobenzylguanidine (123I-mIBG) has been the
ost widely used imaging agent for studying causes
nd effects of cardiac sympathetic nervous system
SNS) abnormality (9), and has been reported to
redict the mortality of patients with HF indepen-
ent of its cause. However, these previous studies
sing 123I-mIBG imaging have focused on the
ccurrence of HF with reduced cardiac function
aused by structural heart disease. We hypothesized
hat SNS abnormality measured by 123I-mIBG
maging would be associated with the occurrence of
F, with the development to permanent AF in
atients with paroxysmal AF and preserved cardiac
unction.
E T H O D S
tudy population. We studied 126 consecutive pa-
ients with a first history of paroxysmal AF at vhowa University Hospital. The condition of ar-
hythmia was diagnosed on the basis of docu-
ented AF by ambulance monitoring, 12-lead
lectrocardiography (ECG), or Holter monitoring.
hey did not have the clinical symptoms of HF
10). The diagnosis of AF was made when visible
-waves on all 12 leads of ECG were absent, and an
rregular random-appearing ventricular response
as present (7). The AF was considered paroxysmal
f the fibrillatory process ended spontaneously after
ome seconds, minutes, hours, or up to 7 days (7).
he patients who had episodes of AF that were not
elf-terminating were considered to have persistent
F despite sinus rhythm, and were distinguished
rom paroxysmal AF. These patients were excluded
rom the entry into this study. Left ventricular
jection fraction (LVEF) and left atrial dimension
LAD) were measured by 2-dimensional echocar-
iography before the study. The patients
ith LVEF 50%, history of valvular
isease including rheumatic cause, con-
enital heart disease, ischemic heart dis-
ase, and cardiomyopathy were excluded
rom this study. Patients were also ex-
luded from this study if they had pre-
xcitation syndrome, supraventricular
achycardia other than AF, or implanted
acemaker before the study. Patients who
ad autonomic nervous system abnormal-
ty such as hyperthyroidism, Parkinson’s
isease, or degenerative cerebral disease,
nd patients who had a history of known
hrombus or vascular events were also
xcluded from this study.
All patients gave written informed con-
ent before this study, and the protocol
as approved by our institutional review board.
ata collected prospectively included demograph-
cs, existing medical diagnoses, symptoms, risk
actors for vascular disease, medications, previous
ardiac procedures, and histories of vascular events.
inally, 123I-mIBG scintigraphy was performed
uring stable sinus rhythm to assess SNS activity in
8 patients (mean  SD; age 66  13 years; 63.3%
ale) with paroxysmal AF who did not have
tructural heart disease and have preserved cardiac
unction. After intravenous injection of 111 MBq
f 123I-mIBG (Dai-ichi Radioisotope Laboratory,
hiba, Japan), the myocardial planner images were
cquired with 4-h delayed images using a standard-
eld gamma camera (PRIZM 2000XP, Picker/
hilips Co., Cleveland, Ohio) as shown in a pre-
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80ulation of 123I-mIBG, the heart/mediastinum
H/M) activity ratio was calculated from the delayed
mage (9,11).
Blood samples were obtained before injection of
23I-mIBG to measure C-reactive protein (CRP).
RP was assayed by a latex immunonephelometric
ethod with an assay range of 0.1 to 30 mg/dl
sing an automatic analyzer (7350 Clinical Ana-
yzer, Hitachi High-Tech Trading Co., Tokyo,
apan). The plasma brain natriuretic peptide (BNP)
evel was also measured using an immunoradiomet-
ic assay (Shionogi RIA, Shionogi Co. Ltd., Osaka,
apan).
ollow-up. The patients were prospectively followed
p to investigate SNS abnormality as 1 of the
redictive markers. The primary end point of this
tudy was the transit to permanent AF. All patients
ere followed up at least every 4 weeks, and were
xamined using 12-lead ECG to observe cardiac
hythm. Direct-current cardioversion and/or phar-
acological therapy were administered to all pa-
ients whose AF persisted and was not self termi-
ating for 1 week. The AF was considered
ermanent if these patients failed to recover the
ondition of sinus rhythm despite those therapies.
he permanent AF was confirmed by the later
CG change during follow-up to be distinguished
rom the persistent AF. The second end point was
he occurrence of HF requiring hospitalization on
he basis of the clinical criterion (the presence of 2
ajor or 1 major and 2 minor criteria; major criteria
ere paroxysmal nocturnal dyspnea or orthopnea,
istended neck veins, rales, radiographic cardiom-
galy, pulmonary edema, third heart sound, in-
reased venous pressure, hepatojugular reflux, and
eight loss on diuretic therapy; minor criteria were
nkle edema, night cough, dyspnea on exertion,
epatomegaly, pleural effusion, pulmonary vascular
edistribution, decrease in vital capacity, and tachy-
ardia) (10,12).
The clinical diagnosis of HF was also confirmed
y dedicated research personnel using a scripted
eview of the medical record. Only the time to
ccurrence of the permanent AF and/of HF was
sed as the end point. The end points were con-
rmed by an independent committee blinded to the
atient’s clinical history.
tatistical analysis. Continuous variables were pre-
ented as mean  SD. Differences between groups
ere tested using an unpaired t test, chi-square test,
r Fisher exact test as appropriate. When the
ariances between each group differed considerably,
e used a nonparametric test (Mann-Whitney U cest). An association between the predictors such as
ge, sex, LAD, LVEF, CRP, and BNP, and the
vents such as transit to permanent AF and/or
ccurrence of HF was formally tested by construc-
ion of Cox proportional hazards model with re-
ression analysis. All multivariable analyses em-
loyed the forward stepwise methods, with entry
nd removal p values set at 0.1. Further, the
ikelihood-ratio test was used to estimate the model
tting. For descriptive purposes, the receiver-
perator characteristic analysis was performed to
efine thresholds for those factors, and the patients
ere divided into 2 groups to perform the log-rank
est using construction of Kaplan-Meier curves.
he statistical analysis was done using SPSS for
indows Version 11 (SPSS Inc., Chicago,
llinois).
E S U L T S
actors perpetuating AF. During 4.0  3.6 years of
ollow-up (up to 13.9 years), 35 patients with
aroxysmal AF transited to permanent AF finally
Fig. 1). Of those 35, 14 patients with permanent
F had a transient process to sinus rhythm (the
ondition of persistent AF) produced by the ther-
pies for a while (Table 1). There were no signifi-
ant differences between the patients with and
ithout the transit to permanent AF in age, sex,
ardiovascular risk factors, and hemodynamic re-
ponses. Risk factors such as obesity or hyperten-
ion were controlled by diet, salt restriction, and
edication after the entry into this study. The SNS
ctivity, LAD, BNP, and LVEF were the factors
hat perpetuated AF (Table 2). In multivariable
nalysis, after adjustment for 5 potential confound-
ng variables, SNS abnormality was an indepen-
ently powerful factor perpetuating AF.
actors resulting in HF with permanent AF. Figure 2
hows the typical 123I-mIBG image examples and
CG strips. These patients with paroxysmal AF
ad the low H/M ratio, which suggests the devel-
pment of AF. HF occurred in 16 patients during
ollow-up, and of those 16, 12 patients were diag-
osed as having permanent AF. The transit to
ermanent AF was associated with the occurrence
f HF (34.3% in 12 of 35 patients with permanent
F vs. 6.3% in 4 of 63 patients without, p 
.0001). The BNP, LAD, SNS activity, LVEF,
nd age were the factors resulting in the occurrence
f HF with permanent AF (Table 3). In multiva-
iable analysis, after adjustment for 5 potential
onfounding variables, SNS abnormality was an
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81ndependently powerful predictor resulting in HF
ith permanent AF.
An SNS abnormality, defined as H/M ratio 2.7,
redicted the occurrence of HF with permanent AF in
3.3% (10 of 12 patients) for the sensitivity and 67.4%
58 of 86 patients) for the specificity (Fig. 3), and was
powerful predictor of events (log-rank chi-square 
5.4, p  0.0001) (Fig. 4). The higher BNP (75
g/ml) and lower LVEF (60%) were also powerful
redictors of the events.
I S C U S S I O N
ur major finding is that SNS abnormality was an
ndependently powerful factor for predicting not
nly the transit to permanent AF but also the
ccurrence of HF with permanent AF in patients
ith paroxysmal AF and preserved cardiac function.
NS abnormality for predicting transit to permanent AF.
he most frequent histopathologic changes in AF
re atrial fibrosis and loss of atrial muscle mass (7).
hese changes contribute to a biological phenom-
non known as “remodeling,” which makes increas-
ngly irreversible electrical and structural properties
f the atrial tissue and cardiac cells. These changes
re important causes of perpetuated AF. Other than
ld age, the established risk factors for promoting
F include cardiac conditions such as HF, valvular
Figure 1. Schematic Time Table Regarding the Temporal Seque
Thirty-ﬁve patients with paroxysmal atrial ﬁbrillation (AF) transited t
had a transient process to persistent AF by the conversion. Sixty-th
63, 5 patients had a process of persistent AF by the conversion.isease, myocardial infarction, and cardiovascular aisk factors (5,6); and subclinical markers indicating
ncreased AF risk include increased arterial stiffness
13), LAD enlargement, left ventricular hypertro-
hy, and left ventricular dysfunction (14). Recently
dentified novel markers associated with increased
isk for AF include the inflammatory and neurohu-
oral biomarkers (15,16). However, despite hun-
reds of publications regarding predictors of devel-
ping AF, it is still difficult to determine an
ndividual patient’s risk of developing AF.
Clinical observations suggest that the onset of an
F episode is often related to variations in auto-
omic tone (17). Altered autonomic tone may be an
mportant mechanism underlying the association of
octurnal oxygen desaturation occurring in patients
ith sleep apnea and incident AF (16). Preliminary
tudies suggest that the modulation of autonomic
one is 1 of the possible beneficial effects of
mega-3 fatty acids in the prevention of AF (18).
hese studies propose that SNS activity itself plays
n important role in both initiation and/or the
aintenance of AF (19). Further, when the com-
ensatory support is needed to meet the demands of
rgan perfusion due to hemodynamic overload, the
ardiac adrenergic system becomes maladaptive to
he heart and may cause the change that increases
usceptibility to persistent AF. However, the sig-
ificance of autonomic factors for promoting AF
of Conversion to Permanent AF
ermanent AF ﬁnally; of those 35, 14 patients with permanent AF
patients with paroxysmal AF remained in sinus rhythm; of thosence
o p
reere poorly understood because there are no effective
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82oninvasive methods capable of defining or moni-
oring autonomic function (5). Recent studies dem-
nstrate the significance of 123I-mIBG imaging as a
arker of SNS activity in patients with structural
eart disease and reduced left ventricular function
9). Mabuchi et al. (20) first reported using 123I-
IBG scintigraphy that SNS abnormality was as-
ociated with AF in 13 patients with permanent AF
Table 1. Patient Characteristics
Variable
Age, yrs
Female
History of diabetes mellitus
History of hypertension
History of hyperlipidemia
History of obesity*
Resting hemodynamics
Resting HR, beats/min
Resting systolic BP, mm Hg
Resting diastolic BP, mm Hg
Electrocardiogram in sinus rhythm
PQ interval, ms
QRS wave duration, ms
QTc interval, ms
Medications
Use of angiotensin-converting enzyme inhibitor
Use of beta-blocker
Use of calcium-channel antagonist
Use of sodium-channel blockers
Use of digoxin
Occurrence of persistent AF
Occurrence of HF
Data are presented as the mean (SD) or n (%). *Obesity was deﬁned as body m
AF  atrial ﬁbrillation; BP  blood pressure; HF  heart failure; HR  heart rate.
it to Permanent Atrial Fibrillation According to Univariable and
Regression
Analysis Univariable Analysis
Coefﬁcient
(Beta)
Hazard Ratio
(95% CI)
Wald
Chi-Square p Va
crease 1.141 3.13 (1.80–5.43) 16.4 0.00
rease 0.072 1.08 (1.03–1.13) 9.69 0.00
0.003 1.003 (1.001–1.004) 7.0 0.00
ease 0.040 1.04 (1.01–1.08) 5.59 0.02
ase 0.027 1.03 (1.00–1.06) 3.16 0.08
crease 0.034 1.04 (0.94–1.14) 0.53 0.47
se 0.015 1.02 (0.96–1.07) 0.31 0.58
0.088 1.09 (0.55–2.15) 0.07 0.80
P  brain natriuretic peptide; CI  conﬁdence interval; CRP  C-reactive protein
ction fraction.nd valvular disease. Recently, we also demon-
trated, using 123I-mIBG imaging, that a combina-
ion of SNS abnormality and high inflammatory
arkers was associated with vascular events in 71
atients with paroxysmal AF (21). We show in the
resent study that SNS activity was associated with
he transit to permanent AF from the paroxysmal
ccurrence.
ransit to
rmanent AF
(n  35)
No Transit to
Permanent AF
(n  63) p Value
68 (10) 65 (14) 0.09
15 (42.9%) 21 (33.3%) 0.35
7 (20%) 6 (9.5%) 0.14
18 (51.4%) 34 (54%) 0.81
8 (22.9%) 17 (27%) 0.65
1 (2.9%) 4 (6.2%) 0.45
75 (21) 77 (19) 0.64
35 (22) 129 (18) 0.21
76 (14) 74 (13) 0.41
70 (29) 166 (35) 0.55
00 (21) 107 (22) 0.14
38 (22) 489 (48) 0.53
16 (45.7%) 27 (42.9%) 0.79
11 (31.4%) 20 (31.7%) 0.97
13 (37.1%) 17 (27%) 0.3
8 (22.9%) 19 (30.2%) 0.44
1 (2.9%) 4 (6.3%) 0.45
14 (40%) 5 (7.9%) 0.0001
12 (34.3%) 4 (6.3%) 0.0001
index 30 kg/m2.
tivariable Analyses
Multivariable Analysis
Likelihood-Ratio
Test p Value
(Chi-Square)
Hazard Ratio
(95% CI)
Wald
Chi-Square p Value
3.44 (1.90–6.21) 16.70 0.0001 0.0001 (17.18)
1.04 (1.01–1.08) 6.08 0.014 0.0001 (21.48)
 cardiothoracic ratio; H/M  heart/mediastinum; LAD  left atrial dimension;T
Pe
1
1
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83NS abnormality for predicting occurrence of HF with
ransit to permanent AF. Although the causative
elationship between AF and HF has not been fully
etermined, their coexistence can be explained to
Figure 2. 123I-mIBG Image Examples and ECG Strips
In these examples of iodine-123 meta-iodobenzylguanidine (123I-mIB
the region of interest on the heart area (H), and the rectangles ind
thetic nervous system activity was estimated by the value of heart/
tion (AF), a 78-year-old man, had 2.7 H/M ratio on 123I-mIBG image
failure (HF). (B) A patient with paroxysmal AF, a 68-year-old man, h
improvement of HF resulted in the recovery to sinus rhythm from A
ratio, and transited to permanent AF. The HF occurred afterward, an
patients with paroxysmal AF had signiﬁcantly lower H/M ratios than
Table 3. Risk of Heart Failure With Permanent Atrial Fibrillation
Variable
Regression
Analysis Univaria
Coefﬁcient
(Beta)
Hazard Ratio
(95% CI)
Plasma BNP, pg/ml,
for each increase
0.005 1.005 (1.002–1.007)
LAD, mm, for each increase 0.122 1.13 (1.04–1.23)
H/M ratio, for each decrease 1.269 3.56 (1.49–8.47)
LVEF, %, for each decrease 0.087 1.09 (1.02–1.16)
Age, yrs, for each increase 0.068 1.07 (1.003–1.142)
CTR, %, for each increase 0.067 1.07 (0.97–1.18)
Serum CRP, mg/dl,
for each increase
0.506 1.66 (0.69–4.01)Abbreviations as in Table 2.ome degree by the presence of common risk factors
s age, hypertension, diabetes, and obesity, as well
s valvular, ischemic, and nonischemic structural
eart disease (2). More important, these factors are
images and electrocardiography (ECG) strips, the ovals indicate
the region of interest on mediastinum area (M). Cardiac sympa-
iastinum (H/M) ratio. (A) A patient with paroxysmal atrial ﬁbrilla-
transited to permanent AF without the occurrence of heart
.6 H/M ratio. The HF with AF occurred afterward, but the
C) A patient with paroxysmal AF, a 71-year-old man. had 2.5 H/M
he AF was perpetuated after the improvement of HF. These
rmal values (vs. 3.3  0.5).
cording to Univariable and Multivariable Analyses
Analysis Multivariable Analysis
Wald
i-Square p Value
Hazard Ratio
(95% CI)
Wald
Chi-Square p Value
13.6 0.0001 1.004 (1.001–1.008) 6.02 0.014
8.79 0.003
8.16 0.004 5.08 (1.46–17.5) 6.04 0.011
7.08 0.008 1.11 (1.03–1.19) 8.67 0.004
4.22 0.040
1.75 0.190
1.27 0.260G)
icate
med
, and
ad 2
F. (
d tAc
ble
Likelihood-Ratio
Test p Value
(Chi-Square)Ch
0.0001 (19.67)
0.0001 (31.52)
0.0001 (26.35)
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84ssociated with myocardial cellular and extracellular
lterations and electrophysiological and neurohu-
oral changes that combine to create an environ-
ent that predisposes the heart to both permanent
F and HF (2). The SNS dysfunction in patients
ith HF has been demonstrated as several neuro-
umoral alterations that are associated with poor
atient prognosis as well as cardiac dysfunction
22). Depleted norepinephrine stores, desensitized
drenoreceptors, and functional autonomic imbal-
nce in the myocardium (23), and increased spill-
ver of norepinephrine from the SNS in the skeletal
uscle (24) and heart (8) are related to the in-
reased plasma concentration and depleted stores in
he failing heart. Many previous studies have re-
orted that SNS abnormality that correlated with
evere cardiac dysfunction is predictive of mortality
n patients with HF (25). Recently, Kasama et al.
26) showed that SNS abnormality correlated with
Figure 3. ROC Curves for Predicting Occurrence of HF With Perm
The receiver-operator characteristics (ROC) curves for predicting occ
indicate that the sensitivity of cardiac sympathetic nervous system
patients, and the speciﬁcity was 67.4% in 58 of 86 patients. The sen
83.3% in 10 of 12 patients, and the speciﬁcity was 68.6% in 59 of 8
(LVEF) (60%) was 75% in 9 of 12 patients, and the speciﬁcity was
Figure 4. Kaplan-Meier Survival Curves
Kaplan-Meier survival curves for predicting occurrence of heart failu
nervous system abnormality (heart/mediastinum ratio [H/M] 2.7),
ventricular ejection fraction (LVEF) (60%) were the powerful predictorNP in patients with HF despite preserved ventric-
lar ejection fraction, suggesting the significance of
NS abnormality for predicting mortality indepen-
ent of cardiac function. Similar to their study, our
esults also indicate the significance of SNS abnor-
ality independent of structural remodeling repre-
ented as LAD enlargement or subsequent severe
ardiac dysfunction.
Jahangir et al. (27) demonstrated that not only
ld age but also proarrhythmic effects were the
ommon factors of development of both permanent
F and HF in 76 patients with idiopathic parox-
smal AF during follow-up, and they suggested that
lectrical remodeling plays an important role for
romoting the development to both permanent AF
nd HF rather than structural remodeling in pa-
ients with paroxysmal AF and preserved cardiac
unction. Surely, in patients with paroxysmal AF,
lectrical remodeling of atria occurs before struc-
ent AF
nce of heart failure (HF) with permanent atrial ﬁbrillation (AF)
rmality (heart/mediastinum ratio 2.7) was 83.3% in 10 of 12
ity of higher brain natriuretic peptide (BNP) (75 pg/ml) was
tients. The sensitivity of lower left ventricular ejection fraction
% in 58 of 86 patients.
HF) with permanent atrial ﬁbrillation (AF). Cardiac sympathetic
er brain natriuretic peptide (BNP) (75 pg/ml), and lower leftan
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85ural remodeling (28), and the electrical remodeling
rolongs the duration of paroxysmal AF (proar-
hythmic effects), which results in HF in patients
ith paroxysmal AF (29). It may result from similar
auses that the value of SNS abnormality was
uperior to that of large LAD for predicting both
vents. The electrical remodeling of atria may
nfluence SNS activity indirectly by the triggering
f myocardial damage that AF causes, for example,
xidative stress.
tudy limitations. In the present study, the small
atient numbers, low event rates, and the relatively
ide range of hazard ratios on Cox proportional
azards model are major limitations. In this respect,
large cohort study given the rarity of the disease,
hich was focused on the arrhythmogenic disease,
hould be started in the near future. We used
edium-energy collimators in the present study
ecause the influences on the planer H/M ratios by
catter or septal penetration were less pronounced
or medium energy. As a result, H/M ratio values
btained in our study patients were higher com-
ared to those of others (9). It is well known that
here is variability in mIBG distribution, and thereImpact of atrial fibrillation on the risk of
thetic nervous syste
the long-term prorom one nuclear medicine center to another in
oth healthy patients and patients with heart dis-
ase (11). We used H/M ratio as a value of SNS
ctivity, similar to our previous studies (11), but the
alue of washout ratio may also be important for
redicting the prognosis (9).
O N C L U S I O N S
ardiac SNS abnormality was associated with the
ccurrence of both HF and permanent AF in
diopathic paroxysmal AF patients. Imaging studies
ith 123I-mIBG imaging may be a useful modality
or predicting the development of AF. Our findings
ay have important implications for the manage-
ent of patients with paroxysmal AF before the
ccurrence of remarkable structural remodeling of
tria and subsequent cardiac dysfunction of the left
entricle caused by AF.
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